Sinem Zeynep Metin

Sinem Zeynep Metin

Auto-generated profile, based on publicly available information

Sinem Zeynep Metin

Department of Psychiatry, Uskudar University, İstanbul, Turkey

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2019 in Clinical Eeg and Neuroscience
Verified
Journal Article
Closed access
PDF file
SMSinem Zeynep Metin
Sinem Zeynep Metin
TATugçe Balli Altuglu
Tugçe Balli Altuglu
BMBaris Metin
Baris Metin
TETurker Tekin Erguzel
Turker Tekin Erguzel
SYSelin Yigit
Selin Yigit
KTKasif Nevzat Tarhan
Kasif Nevzat Tarhan
Aim. In this study we assessed the predictive power of quantitative EEG (qEEG) for the treatment response to right frontal transcranial magnetic stimulation (TMS) in obsessive compulsive disorder (OCD) using a machine learning approach. Method. The study included 50 OCD patients (35 responsive to TMS, 15 nonresponsive) who were treated with right frontal low frequency stimulation and identified retrospectively from Uskudar Unversity, NPIstanbul Brain Hospital outpatient clinic. All patients were diagnosed with OCD according to the DSM-IV-TR and DSM-5 criteria. We first extracted pretreatment band powers for patients. To explore the prediction accuracy of pretreatment EEG, we employed machine learning methods using an artificial neural network model. Results. Among 4 EEG bands, theta power successfully discriminated responsive from nonresponsive patients. Responsive patients had more theta powers for all electrodes as compared to nonresponsive patients. Discussion. qEEG could be helpful before deciding about treatment strategy in OCD. The limitations of our study are moderate sample size and limited number of nonresponsive patients and that treatment response was defined by clinicians and not by using a formal symptom measurement scale. Future studies with larger samples and prospective design would show the role of qEEG in predicting TMS response better.

1 July 2013 in Epilepsy & Behavior
Verified
Journal Article
Closed access
SMSinem Zeynep Metin
Sinem Zeynep Metin
MOMine Ozmen
Mine Ozmen
BMBaris Metin
Baris Metin
STSeren Talasman
Seren Talasman
SYSeher Naz Yeni
Seher Naz Yeni
COCigdem Ozkara
Cigdem Ozkara

1 March 2013 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
SMSinem Zeynep Metin
Sinem Zeynep Metin
MOMine Ozmen
Mine Ozmen
CÖCigdem Özkara
Cigdem Özkara
EOEmre Ozmen
Emre Ozmen

9 September 2024 in Clinical Eeg and Neuroscience
Verified
Journal Article
Closed access
SMSinem Zeynep Metin
Sinem Zeynep Metin
ÇUÇağlar Uyulan
Çağlar Uyulan
SFShams Farhad
Shams Farhad
TETürker Tekin Ergüzel
Türker Tekin Ergüzel
ÖTÖmer TÜRK
Ömer TÜRK
NTNevzat Tarhan
Nevzat Tarhan
Background: Although there are many treatment options available for depression, a large portion of patients with depression are diagnosed with treatment-resistant depression (TRD), which is characterized by an inadequate response to antidepressant treatment. Identifying the TRD population is crucial in terms of saving time and resources in depression treatment. Recently several studies employed various methods on EEG datasets for automatic depression detection or treatment outcome prediction. However, no previous study has used the deep learning (DL) approach and EEG signals for detecting treatment resistance. Method: 77 patients with TRD, 43 patients with non-TRD, and 40 healthy controls were compared using GoogleNet convolutional neural network and DL on EEG data. Additionally, Class Activation Maps (CAMs) acquired from the TRD and non-TRD groups were used to obtain distinctive regions for classification. Results: GoogleNet classified the healthy controls and non-TRD group with 88.43%, the healthy controls and TRD subjects with 89.73%, and the TRD and non-TRD group with 90.05% accuracy. The external validation accuracy for the TRD-non-TRD classification was 73.33%. Finally, the CAM analysis revealed that the TRD group contained dominant features in class detection of deep learning architecture in almost all electrodes. Limitations: Our study is limited by the moderate sample size of clinical groups and the retrospective nature of the study. Conclusion: These findings suggest that EEG-based deep learning can be used to classify treatment resistance in depression and may in the future prove to be a useful tool in psychiatry practice to identify patients who need more vigorous intervention.

9 January 2024 in Clinical Eeg and Neuroscience
Verified
Journal Article
Closed access
SFShams Farhad
Shams Farhad
SMSinem Zeynep Metin
Sinem Zeynep Metin
ÇUÇağlar Uyulan
Çağlar Uyulan
SMSahar Taghi Zadeh Makouei
Sahar Taghi Zadeh Makouei
BMBarış Metin
Barış Metin
NTNevzat Tarhan
Nevzat Tarhan
Objective: Obsessive-compulsive disorder (OCD) is a highly common psychiatric disorder. The symptoms of this condition overlap and co-occur with those of other psychiatric illnesses, making diagnosis difficult. The availability of biomarkers could be useful for aiding in diagnosis, although prior neuroimaging studies were unable to provide such biomarkers. Method: In this study, patients with OCD were classified from healthy controls using 2 different hybrid deep learning models: one-dimensional convolutional neural networks (1DCNN) together with long-short term memory (LSTM) and gradient recurrent units (GRU), respectively. Results: Both models exhibited exceptional classification accuracies in cross-validation and external validation phases. The mean classification accuracies in the cross-validation stage were 90.88% and 85.91% for the 1DCNN-LSTM and 1DCNN-GRU models, respectively. The inferior frontal, temporal, and occipital electrodes were predominant in providing discriminative features. Conclusion: Our findings underscore the potential of hybrid deep learning architectures utilizing EEG data to effectively differentiate patients with OCD from healthy controls. This promising approach holds implications for advancing clinical decision-making by offering valuable insights into diagnostic markers for OCD.

29 June 2022 in Bezmialem Science
Verified
Journal Article
Closed access
SMSinem Zeynep Meti̇n
Sinem Zeynep Meti̇n